Filing Flows › Vir Biotechnology (VIR) › Q4 2025 › vs Q4 2024
Vir Biotechnology (VIR) Q4 2025 vs Q4 2024 (year over year)
Vir Biotechnology's revenue rose $51.7M (+418%) from $12.4M in Q4 2024 to $64.1M in Q4 2025.
Vir Biotechnology, Q4 2025: revenue $64.1M (+418% year over year), operating margin -74.8%, net loss $42.9M, operating cash flow −$25.9M. The chart draws each line against Q4 2024, the increases inside each band.
Every line
| Line | Q4 2025 | Q4 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $64.1M | $12.4M | $51.7M | +418% |
| Other income, net | $4.9M | $12.5M | −$7.6M | -61% |
| Income tax benefit | $137K | $86K | $51K | +59% |
| Net loss | $42.9M | $105M | −$61.7M | -59% |
| Costs & expenses | $112M | $130M | −$17.5M | -14% |
| Operating costs | $112M | $130M | −$17.5M | -14% |
| Operating cash sources | $42.9M | $105M | −$61.7M | -59% |
| Depreciation & amortization | $2.9M | $2.9M | $12K | +0.4% |
| Share-based compensation | $11.2M | $15.8M | −$4.6M | -29% |
| Working capital & other | $2.9M | −$1.8M | $4.7M | — |
| Cash used in operations | $25.9M | $87.6M | −$61.8M | -70% |
| Net loss absorbed | $42.9M | $105M | −$61.7M | -59% |
Questions
How much did Vir Biotechnology's revenue grow year over year in Q4 2025?
Vir Biotechnology's revenue rose $51.7M (+418%) from $12.4M in Q4 2024 to $64.1M in Q4 2025.